B

Bergenbio ASA
OSE:BGBIO

Watchlist Manager
Bergenbio ASA
OSE:BGBIO
Watchlist
Price: 6.45 NOK -11.19% Market Closed
Market Cap: 261.9m NOK
Have any thoughts about
Bergenbio ASA?
Write Note

Bergenbio ASA
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bergenbio ASA
Additional Paid In Capital Peer Comparison

Comparables:
HBC
L
LYTIX
AZT
N
NYKD
T
TRMED

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
B
Bergenbio ASA
OSE:BGBIO
Additional Paid In Capital
kr8.8m
CAGR 3-Years
-73%
CAGR 5-Years
-50%
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
L
Lytix Biopharma AS
OSE:LYTIX
Additional Paid In Capital
kr47.3m
CAGR 3-Years
40%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Additional Paid In Capital
kr263.9m
CAGR 3-Years
1%
CAGR 5-Years
12%
CAGR 10-Years
8%
N
Nykode Therapeutics ASA
OSE:NYKD
Additional Paid In Capital
$129m
CAGR 3-Years
28%
CAGR 5-Years
17%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Additional Paid In Capital
kr61.5m
CAGR 3-Years
-51%
CAGR 5-Years
-40%
CAGR 10-Years
-6%

See Also

What is Bergenbio ASA's Additional Paid In Capital?
Additional Paid In Capital
8.8m NOK

Based on the financial report for Jun 30, 2024, Bergenbio ASA's Additional Paid In Capital amounts to 8.8m NOK.

What is Bergenbio ASA's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
-50%

The average annual Additional Paid In Capital growth rates for Bergenbio ASA have been -73% over the past three years , -50% over the past five years .

Back to Top